APA (7th ed.) Citation

Mocci, G., Tursi, A., Scaldaferri, F., Napolitano, D., Pugliese, D., Maconi, G., . . . Ribaldone, D. G. (2025). Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study. Journal of Clinical Medicine, 14(21), 7801. https://doi.org/10.3390/jcm14217801

Chicago Style (17th ed.) Citation

Mocci, Giammarco, et al. "Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study." Journal of Clinical Medicine 14, no. 21 (2025): 7801. https://doi.org/10.3390/jcm14217801.

MLA (9th ed.) Citation

Mocci, Giammarco, et al. "Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study." Journal of Clinical Medicine, vol. 14, no. 21, 2025, p. 7801, https://doi.org/10.3390/jcm14217801.